Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), Growth Differentiation Factor-15 (GDF-15), and Soluble C5b-9 (sC5b-9) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell Recipients.

chimeric antigen receptor-T (CAR-T) complement cytokine release syndrome (CRS) endothelial activation and stress index (EASIX) endothelial dysfunction growth differentiation factor-15 (GDF-15) immune effector cell-associated neurotoxicity syndrome (ICANS) soluble urokinase plasminogen activator receptor (suPAR)

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
14 Oct 2024
Historique:
received: 26 08 2024
revised: 09 10 2024
accepted: 13 10 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 26 10 2024
Statut: epublish

Résumé

Endothelial injury indices, such as Endothelial Activation and Stress Index (EASIX), modified EASIX (m-EASIX), and simplified EASIX (s-EASIX) scores, have been previously associated with chimeric antigen receptor-T (CAR-T) cell immunotherapy complications. Soluble urokinase-type plasminogen activator receptor (suPAR), growth differentiation factor-15 (GDF-15), and soluble C5b-9 (sC5b-9) have been described as markers of endothelial injury post-hematopoietic stem cell transplantation. In the current study, we examined whether suPAR, GDF-15, and sC5b-9 levels were associated with endothelial injury indices in adult CAR-T cell recipients. The levels of these markers were measured in patients before CAR-T cell infusion and in healthy individuals with immunoenzymatic methods. We studied 45 CAR-T cell recipients and 20 healthy individuals as the control group. SuPAR, GDF-15, and sC5b-9 levels were significantly higher in the patients' group compared to the healthy control group (

Identifiants

pubmed: 39456810
pii: ijms252011028
doi: 10.3390/ijms252011028
pii:
doi:

Substances chimiques

Growth Differentiation Factor 15 0
Receptors, Urokinase Plasminogen Activator 0
GDF15 protein, human 0
Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Eleni Gavriilaki (E)

BMT Unit, Hematology Department, George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.
Second Propedeutic Department of Internal Medicine, Hippocration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.

Christos Demosthenous (C)

BMT Unit, Hematology Department, George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.

Paschalis Evangelidis (P)

Second Propedeutic Department of Internal Medicine, Hippocration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.

Zoi Bousiou (Z)

BMT Unit, Hematology Department, George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.

Ioannis Batsis (I)

BMT Unit, Hematology Department, George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.

Anna Vardi (A)

BMT Unit, Hematology Department, George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.

Despina Mallouri (D)

BMT Unit, Hematology Department, George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.

Eudoxia-Evaggelia Koravou (EE)

BMT Unit, Hematology Department, George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.

Nikolaos Spyridis (N)

BMT Unit, Hematology Department, George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.

Alkistis Panteliadou (A)

BMT Unit, Hematology Department, George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.

Georgios Karavalakis (G)

BMT Unit, Hematology Department, George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.

Marianna Masmanidou (M)

BMT Unit, Hematology Department, George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.

Tasoula Touloumenidou (T)

BMT Unit, Hematology Department, George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.

Apostolia Papalexandri (A)

BMT Unit, Hematology Department, George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.

Christos Poziopoulos (C)

Department of Hematology, Metropolitan Hospital, 18547 Athens, Greece.

Evangelia Yannaki (E)

BMT Unit, Hematology Department, George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.

Ioanna Sakellari (I)

BMT Unit, Hematology Department, George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.

Marianna Politou (M)

Thrombosis-Bleeding-Transfusion Medicine Postgraduate Studies, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Hematology Laboratory-Blood Bank, Aretaieion Hospital, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.

Ioannis Papassotiriou (I)

First Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH